These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 24824206)

  • 1. [Assertive community treatment in patients with severe obsessive-compulsive disorders].
    Strauß M; Jahn I; Olbrich S; Beyrich-Kolbus U; Stengler K
    Fortschr Neurol Psychiatr; 2014 May; 82(5):275-9. PubMed ID: 24824206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychometric analysis of the Yale-Brown Obsessive-Compulsive Scale Second Edition Symptom Checklist.
    Storch EA; Larson MJ; Price LH; Rasmussen SA; Murphy TK; Goodman WK
    J Anxiety Disord; 2010 Aug; 24(6):650-6. PubMed ID: 20471199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of Intensive Cognitive Behaviour Therapy in a Residential Setting for People with Severe Obsessive Compulsive Disorder: A Large Open Case Series.
    Veale D; Naismith I; Miles S; Childs G; Ball J; Muccio F; Darnley S
    Behav Cogn Psychother; 2016 May; 44(3):331-46. PubMed ID: 26122913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS): an instrument for assessing obsessive-compulsive symptom dimensions.
    Rosario-Campos MC; Miguel EC; Quatrano S; Chacon P; Ferrao Y; Findley D; Katsovich L; Scahill L; King RA; Woody SR; Tolin D; Hollander E; Kano Y; Leckman JF
    Mol Psychiatry; 2006 May; 11(5):495-504. PubMed ID: 16432526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Course of obsessive-compulsive disorder during early postpartum period: a prospective analysis of 16 cases.
    Uguz F; Gezginc K; Zeytinci IE; Karatayli S; Askin R; Guler O; Sahin FK; Emul HM; Ozbulut O; Gecici O
    Compr Psychiatry; 2007; 48(6):558-61. PubMed ID: 17954142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Convergent and discriminant validity of the Children's Yale-Brown Obsessive Compulsive Scale-Symptom Checklist.
    Gallant J; Storch EA; Merlo LJ; Ricketts ED; Geffken GR; Goodman WK; Murphy TK
    J Anxiety Disord; 2008 Dec; 22(8):1369-76. PubMed ID: 18329843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep brain stimulation for treatment-refractory obsessive-compulsive disorder: psychopathological and neuropsychological outcome in three cases.
    Gabriëls L; Cosyns P; Nuttin B; Demeulemeester H; Gybels J
    Acta Psychiatr Scand; 2003 Apr; 107(4):275-82. PubMed ID: 12662250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features of pure obsessive-compulsive disorder.
    Torres AR; Shavitt RG; Torresan RC; Ferrão YA; Miguel EC; Fontenelle LF
    Compr Psychiatry; 2013 Oct; 54(7):1042-52. PubMed ID: 23746710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring obsessive-compulsive symptoms: Padua Inventory-Revised vs. Yale-Brown Obsessive Compulsive Scale.
    Anholt GE; van Oppen P; Emmelkamp PM; Cath DC; Smit JH; van Dyck R; van Balkom AJ
    J Anxiety Disord; 2009 Aug; 23(6):830-5. PubMed ID: 19443176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The validation of the Hungarian version of the dimensional Yale-Brown obsessive-compulsive scale.
    Harsányi A; Csigó K; Rajkai C; Döme L; Demeter G; Racsmány M
    Ideggyogy Sz; 2012 Jan; 65(1-2):25-33. PubMed ID: 22338843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congruence and discrepancy between self-rated and clinician-rated symptom severity on the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) before and after a low-intensity intervention.
    Hauschildt M; Dar R; Schröder J; Moritz S
    Psychiatry Res; 2019 Mar; 273():595-602. PubMed ID: 30716599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Florida Obsessive-Compulsive Inventory: development, reliability, and validity.
    Storch EA; Kaufman DA; Bagner D; Merlo LJ; Shapira NA; Geffken GR; Murphy TK; Goodman WK
    J Clin Psychol; 2007 Sep; 63(9):851-9. PubMed ID: 17674398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hungarian translation of the Dimensional Yale-Brown Obsessive-Compulsive Scale and our first experiences with the test].
    Harsányi A; Csigó K; Demeter G; Rajnai C; Németh A; Racsmány M
    Psychiatr Hung; 2009; 24(1):18-59. PubMed ID: 19542567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor structure of the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) in a large sample of patients with schizophrenia or related disorders and comorbid obsessive-compulsive symptoms.
    Boyette L; Swets M; Meijer C; Wouters L;
    Psychiatry Res; 2011 Apr; 186(2-3):409-13. PubMed ID: 20800902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Change in metacognitions predicts outcome in obsessive-compulsive disorder patients undergoing treatment with exposure and response prevention.
    Solem S; Håland AT; Vogel PA; Hansen B; Wells A
    Behav Res Ther; 2009 Apr; 47(4):301-7. PubMed ID: 19203749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose escitalopram for the treatment of obsessive-compulsive disorder.
    Rabinowitz I; Baruch Y; Barak Y
    Int Clin Psychopharmacol; 2008 Jan; 23(1):49-53. PubMed ID: 18090508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Yale-Brown Obsessive Compulsive Scale: factor analysis, construct validity, and suggestions for refinement.
    Deacon BJ; Abramowitz JS
    J Anxiety Disord; 2005; 19(5):573-85. PubMed ID: 15749574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The Yale-Brown Scale: instrument for assessing the severity of obsessive-compulsive disorders].
    Kiejna A; Grzesiak M; Małyszczak K
    Psychiatr Pol; 1998; 32(1):69-76. PubMed ID: 9594585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of early maladaptive schemas in predicting exposure and response prevention outcome for obsessive-compulsive disorder.
    Haaland AT; Vogel PA; Launes G; Haaland VØ; Hansen B; Solem S; Himle JA
    Behav Res Ther; 2011 Nov; 49(11):781-8. PubMed ID: 21920500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptom dimensions in obsessive-compulsive disorder: factor analysis on a clinician-rated scale and a self-report measure.
    Denys D; de Geus F; van Megen HJ; Westenberg HG
    Psychopathology; 2004; 37(4):181-9. PubMed ID: 15240990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.